Nancy J. Hutson - Oct 29, 2021 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
CLSD
Transactions as of
Oct 29, 2021
Transactions value $
$81,350
Form type
4
Date filed
11/2/2021, 04:40 PM
Previous filing
Oct 19, 2021
Next filing
Nov 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Options Exercise $50K +25K +192.31% $2.00 38K Oct 29, 2021 Direct
transaction CLSD Common Stock Options Exercise $31.4K +15K +39.47% $2.09 53K Oct 29, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Stock Option (right to buy) Options Exercise $0 -25K -100% $0.00* 0 Oct 29, 2021 Common Stock 25K $2.00 Direct F1
transaction CLSD Stock Option (right to buy) Options Exercise $0 -15K -50% $0.00 15K Oct 29, 2021 Common Stock 15K $2.09 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option were fully vested as of June 18, 2021.
F2 This option will vest and become exercisable in 36 equal monthly installments beginning on May 21, 2020, subject to the Reporting Person's continuous service as of such vesting dates.